Type 2 Diabetes

New data from a pair of New Orleans-based hospitals suggests metabolic syndrome in Black patients with COVID-19 was associated with increased mortality.

Using data from a group of RCTs, investigators determined semaglutide was associated with greater reductions in HbA1c and weight loss than empagliflozin.

Data from more than 4500 diabetics suggest CAC was better at predicting CVD and all-cause mortality in women than in men.

An endocrinologist from New Jersey discusses the importance of flu shots in high-risk diabetic patients.

A study comparing 22 patients is offering a detailed overview of the effects of weight loss as a result of gastric bypass surgery and diet alone in obese patients.

An analysis of NHANES data suggests those who lost weight between early adulthood and midlife could have drastically reduced their risk of mortality.

A professor from Michigan Medicine discusses recent research from the institute and how protocols implemented at Michigan Medicine to manage the increased risk of severe outcomes associated with hyperglycemia in COVID-19.

An analysis of data from England details the increased odds of mortality associated with type 1 and type 2 diabetes in COVID-19 patients.

A single nucleotide polymorphism is associated with severe and proliferative retinopathy risk reduction by 42% and 63%, respectively.

An analysis of data from the UK and Canada has found no significant increase in below-knee amputations with SGLT2 inhibitor use versus DPP-4 inhibitor use.

Treatment with the PCSK9 Inhibitor did not increase risk of safety events, including new-onset diabetes.

Results of a web-based survey indicate the rate of new type 1 diabetes diagnoses dropped nearly 25% during the early phases of the COVID-19 pandemic.

New data suggests addition of HbA1c testing could improve youth diabetes screenings in the US compared to current screening standards.

An endocrinologist from New Jersey reflects on whether or not the management of type 2 diabetes should fall under the umbrella of primary care specialists rather than endocrinologists as diabetes become more prevalent.

An analysis of patient data from Europe suggests an increased number of infections requiring antibiotic use was tied to an elevated risk of coronary heart disease in type 1 diabetics.

Data from a prospective cohort study in Europe indicates increased antibiotic use and LPS activity levels were tied to increased incidence of coronary heart disease events.

Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.

A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time.

A systematic review and meta-analysis is detailing the risks of new-onset and recurrent heart failure, separately, in patients with diabetes mellitus.

A systematic review and meta-analysis found bariatric surgery in obese patients was linked to decreases of more than 35% in risk of all-cause and cardiovascular mortality.

An endocrinologist offers perspective on his reaction to EMPEROR-REDUCED topline results and what he hopes to see from the full results at ESC 2020.

A nationwide assessment of data published between 2000-2020 related to outcomes following bariatric surgery is revealing more about its benefits on mortality and incidence of obesity-related disease.

A new University of Michigan-led study is detailing the effects of national cost-sharing caps on insulin for type 1 diabetics.

Melissa Young, MD, discusses how she addresses questions from patients related to returning to work or back to school during the ongoing COVID-19 pandemic.

Eyes with moderate to severe nonproliferative diabetic retinopathy more often develop eye worsening compared to those with a milder form of the condition.